CHRISTIE MORRISON: Open Payments
NPI 1760875165 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$114,552 in 191 payments from 11 companies in 2025. Trend: 2023 $13,806 · 2024 $94,820 · 2025 $114,552
Speaker / faculty: $73,750Travel & lodging: $31,493Consulting: $5,416Food & beverage: $3,893
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 149 | $103,489 |
| Lilly USA, LLC | 13 | $6,124 |
| PFIZER INC. | 6 | $2,531 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $1,370 |
| Janssen Biotech, Inc. | 13 | $757 |
| Madrigal Pharmaceuticals | 1 | $125 |
| Celltrion USA Inc. | 2 | $47 |
| Exact Sciences Corporation | 1 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $40 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
Products named: SKYRIZI, RINVOQ, OMVOH, VELSIPITY, TREMFYA, LINZESS, REZDIFFRA, ENTYVIO.
Industry payments across TX — which companies pay providers there.
